Warfarin and the inhibition of vitamin K activity by an oxide metabolite.
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D008099:Liver / Q000378:metabolism; D008297:Male; D010087:Oxides; D011517:Prothrombin Time; D051381:Rats; D013501:Surface-Active Agents / Q000494:pharmacology; D014812:Vitamin K / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000494:pharmacology; D010837:Vitamin K 1 / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D014859:Warfarin / Q000008:administration & dosage / Q000494:pharmacology*
D010087:Oxides; D013501:Surface-Active Agents; D014812:Vitamin K; D014859:Warfarin; D010837:Vitamin K 1